AllianceBernstein’s Rubius Therapeutics, Inc RUBY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-60,200
| Closed | -$332K | – | 3431 |
|
|
2022
Q1 | $332K | Buy |
60,200
+200
| +0.3% | +$1.1K | ﹤0.01% | 2831 |
|
|
2021
Q4 | $581K | Hold |
60,000
| – | – | ﹤0.01% | 2658 |
|
|
2021
Q3 | $1.07M | Sell |
60,000
-3,100
| -5% | -$55.4K | ﹤0.01% | 2460 |
|
|
2021
Q2 | $1.54M | Buy |
63,100
+3,900
| +7% | +$95.2K | ﹤0.01% | 2321 |
|
|
2021
Q1 | $1.57M | Sell |
59,200
-18,800
| -24% | -$498K | ﹤0.01% | 2204 |
|
|
2020
Q4 | $592K | Sell |
78,000
-3,200
| -4% | -$24.3K | ﹤0.01% | 2505 |
|
|
2020
Q3 | $407K | Sell |
81,200
-2,100
| -3% | -$10.5K | ﹤0.01% | 2635 |
|
|
2020
Q2 | $498K | Buy |
83,300
+14,100
| +20% | +$84.3K | ﹤0.01% | 2603 |
|
|
2020
Q1 | $308K | Buy |
69,200
+23,700
| +52% | +$105K | ﹤0.01% | 2600 |
|
|
2019
Q4 | $432K | Sell |
45,500
-2,769,072
| -98% | -$26.3M | ﹤0.01% | 2593 |
|
|
2019
Q3 | $22.1M | Buy |
2,814,572
+302,120
| +12% | +$2.37M | 0.01% | 750 |
|
|
2019
Q2 | $39.5M | Buy |
2,512,452
+11,438
| +0.5% | +$180K | 0.02% | 605 |
|
|
2019
Q1 | $45.3M | Buy |
2,501,014
+216,967
| +9% | +$3.93M | 0.03% | 550 |
|
|
2018
Q4 | $36.7M | Buy |
2,284,047
+657,192
| +40% | +$10.6M | 0.03% | 570 |
|
|
2018
Q3 | $39M | Buy |
+1,626,855
| New | +$39M | 0.03% | 605 |
|